Compare BHVN & APPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHVN | APPN |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 2022 | 2017 |
| Metric | BHVN | APPN |
|---|---|---|
| Price | $11.25 | $27.11 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 6 |
| Target Price | $27.69 | ★ $33.83 |
| AVG Volume (30 Days) | ★ 1.9M | 1.4M |
| Earning Date | 01-01-0001 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 101.59 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $226,743,000.00 |
| Revenue This Year | N/A | $12.18 |
| Revenue Next Year | N/A | $11.43 |
| P/E Ratio | ★ N/A | $1,316.50 |
| Revenue Growth | N/A | ★ 28.29 |
| 52 Week Low | $7.48 | $21.77 |
| 52 Week High | $37.36 | $46.06 |
| Indicator | BHVN | APPN |
|---|---|---|
| Relative Strength Index (RSI) | 45.94 | 51.77 |
| Support Level | $10.75 | $21.77 |
| Resistance Level | $11.80 | $31.83 |
| Average True Range (ATR) | 0.63 | 1.65 |
| MACD | -0.05 | 0.61 |
| Stochastic Oscillator | 16.63 | 93.08 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.